5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

Daniel G. Haller, Josep Tabernero, Jean A. Maroun, Filippo de Braud, T.J. Price, Eric Van Cutsem, Micah Hill, Frank Gilberg, Karen Rittweger, Hans‐Joachim Schmoll

European Journal of Cancer Supplements · 2009 · 38 citations · 0 references

Concepts